| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.03 |